| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,732 |
5,752 |
$462K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,690 |
1,450 |
$172K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
2,341 |
2,067 |
$67K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
957 |
862 |
$66K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
1,170 |
1,102 |
$59K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,893 |
2,540 |
$31K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
250 |
222 |
$17K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,457 |
622 |
$16K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
895 |
760 |
$13K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
106 |
87 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
72 |
63 |
$1K |
| 71046 |
Radiologic examination, chest; 2 views |
50 |
40 |
$945.45 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
573 |
466 |
$863.38 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
12 |
12 |
$434.50 |
| 99051 |
|
22 |
22 |
$297.80 |
| 87807 |
|
14 |
14 |
$140.48 |
| 99070 |
|
65 |
55 |
$0.00 |